Two-engine growth thesis, execution risk on unproven GScale pivot

₹247.7 Cr revenue, 43.1% YoY growth, in-line with historical growth

Delivered 16.0% OPM, 10.6% NPM; 44 Cr on 250 Cr = 17.6% margin. YoY EBITDA growth ~27% plausible

Unexecuted; factory ramp Nov 2026, only LOIs advanced. Revenue recognition risky 4-month window

Q1 FY27 ₹247.7 Cr implies ~₹1,048 Cr annualized at current run-rate; 40-50% growth guidance requires acceleration

Stated on call, unverified externally; 50% CDMO, 50% pharma/chemical split claimed

Prior: 'exceeding 26.7%' (FY26 baseline). Current: 40-50% FY27. Driver: CDMO capex cycle, pharma customer tailwind.

INR 250 Cr revenue guidance FY27. Factory 4 lakh sqft, ₹500 Cr capex, aims 23-25% EBITDA margin. Market: India data center 6x CAGR via AI/cloud.

INR 71 Cr investment; 20-yr glass-lining heat exchanger license; 2-3 yr path to 51% stake. Target GL Hakko ₹200 Cr → ₹400 Cr revenue.

Guided 17-18% core EBITDA (prior: margin recovery expected). Q1 delivered 16.0% OPM; slight underperformance vs 17.5% EBITDA claim.

Prior 3-yr aspiration: ₹1,600 Cr. Current: ₹1,450 Cr (₹1,200 core + ₹250 GScale) FY27. Interim pivot; clarity pending on FY28 consolidation.

Power products, cooling, modular systems. 5 active customer inquiries (3 global MNCs, 2 India). Target ₹250 Cr revenue FY27. Brahma: 23-25% EBITDA expected.

No global competitors in shell & tube heat exchangers or low-leaching glass. Nageswara: 80% manufactured Japan (IP protection), 20% India assembly. TAM ₹2,000 Cr India, USD 2B global.

Nageswara: 20% ROE expected, possibly higher. Will guide on exact revenue/ROA later.

Brahma: Traditional 24-36 mo. GScale 15-18 mo via skid-mount pre-manufacturing. Reduces construction & integration time.

Nageswara: CDMO ~50%, balance pharma/chemical. Mix reflects capex cycle tailwind.

Nageswara: Inventory managed flat (same stock level), customer advances growing, receivables collection improving. GScale <150 days (project advances).

Operating leverage + financial leverage mix. Maintain 17-18% going forward. Manpower investments + mechanization are temporary headwinds.

Nageswara: Q1 only 2-3% exports (global macro uncertainty). Q2 guidance 5-6%. Cost headwind acknowledged but no specific quantification.

Brahma: 3 global hyper-scalers + 2 India data center players. Names withheld (NDAs). Excitement high, LOIs active.

Nageswara: No tech transfer agreement currently. Critical products stay Japan (IP protection vs competitors). Non-critical India-made.

Core: ₹1,200 Cr from ₹248 Q1 base requires 40-50% YoY. Backed by ₹1,400 Cr order book and CDMO capex cycle. GScale: factory ramp Nov, LOIs only, 4-month execution window high-risk.

GL Hakko ₹200 Cr baseline not yet consolidated; contribution unclear. GScale ₹250 Cr is 100% new business, unproven.

Q1 delivered 16.0% OPM vs claimed 17.5% EBITDA; slight miss. Manpower investments cited as temporary. GScale margin unproven; based on partner product benchmarks, not actual run.

Equipment on order globally; mid-Sep arrival, Nov ops target. Phase 2 (2 lakh sqft) by Dec 2026. Phases 3 & 4 to follow.

₹250 Cr FY27 target rests on Nov 2026 factory commissioning, 5 customer LOI conversions, and product-market fit in data center manufacturing. Zero revenue history. 4-month window for ₹250 Cr is 2.5x typical quarterly run-rate.

Only 5 active data center customer inquiries. No long-term purchase commitments disclosed. Hyper-scalers (Amazon, Google, Meta) have bargaining power and can backward-integrate or switch suppliers. Moat based on 'integrated solution + speed' but replicable by incumbents (Schneider, ABB) if they choose to bundle.

₹71 Cr investment at 19.9% stake; glass-lining critical products (80% of value) manufactured in Japan only, with no tech transfer commitment. If GL Hakko relationship breaks or technology is obsoleted, SETL loses moat. 2-3 yr path to 51% ownership depends on ₹400 Cr revenue milestone (DouBLING) — ambitious and unproven.

Q1 OPM 16.0% vs guided 17.5% EBITDA; flat YoY despite 43% revenue growth. Manpower investments + mechanization capex offsetting scale. If revenue misses 40-50% growth, fixed cost leverage evaporates and margins compress further below 16%.

Glass-lining equipment TAM India ₹1,500 Cr only. Even at ₹1,200 Cr guided FY27, SETL will capture ~80% of total addressable market. Requires international expansion or adjacent products to sustain 40-50% growth beyond FY27-FY28.

₹500 Cr capex over 2 years for GScale on aggressive timeline (2 lakh sqft by Nov 2026). Robotic equipment sourced globally mid-Sep arrival; civil + electrical integration concurrent. Delays could push revenue recognition to FY28, missing FY27 guidance.